BioCentury
ARTICLE | Company News

Agenix, Akzo Nobel NV deal

August 15, 2005 7:00 AM UTC

AKZ's Diosynth Biotechnology unit will manufacture AGX's ThromboView for Phase III trials and commercial sales. The radiolabeled monoclonal antibody is in Phase II testing as an imaging agent to detec...